Fingerprint
Dive into the research topics of 'Dual biologic therapy with Vedolizumab and Ustekinumab for refractory Crohn's disease in children'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Dual biologic therapy with Vedolizumab and Ustekinumab for refractory Crohn's disease in children
Gadi Howard, Dror Weiner, Itzhak Bar-Or, Arie Levine*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
10
Scopus
citations